Skip to content

Clinical trials

Pulmonary Fibrosis trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pulmonary Fibrosis Country / region: Canada Clear all

31 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20051
20071
20081
20103
20112
20131
20141
20151
20171
20181
20204
20211
20221
20235
20243
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed13
Terminated6
Active, not recruiting4
Recruiting4
Unknown status3
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bristol-Myers Squibb5
Boehringer Ingelheim3
Celgene2
Endeavor Biomedicines, Inc.2
Amgen1
Avalyn Pharma Inc.1
Bellerophon Pulse Technologies1
Centocor, Inc.1
Centre hospitalier de l'Université de Montréal (CHUM)1
Contineum Therapeutics1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pulmonary Fibrosis31
Idiopathic Pulmonary Fibrosis13
Lung Diseases, Interstitial11
Pulmonary Disease, Chronic Obstructive6
Fibrosis4
Hypertension, Pulmonary3
Idiopathic Interstitial Pneumonias3
Asthma2
Bronchiectasis2
Cystic Fibrosis2

Trials

Showing 76 to 31 of 31. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.